NACHT MARIUS 13D and 13G filings for Protalix BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-02 06:36 am Sale | 2023-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX | NACHT MARIUS | 2,208,913 2.900% | -607,988 (-21.58%) | Filing |
| 2023-01-03 06:01 am Unchanged | 2022-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX | NACHT MARIUS | 2,816,901 5.300% | 0 (Unchanged) | Filing |
| 2022-01-31 07:16 am Sale | 2021-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX | NACHT MARIUS | 2,816,901 5.800% | -570,421 (-16.84%) | Filing |